ACT

Duloxetine associated tinnitus

I have a patient with c/o ringing in the ear since beginning duloxetine.  The package insert reports <1% in clinical trials.  Has anyone seen duloxetine-associated tinnitus in their practice?   Thanks   ...

The Equality Act 2010 and mental health.

Lockwood G, Henderson C, Thornicroft G  | | |  

Lamotrigine and OC's

Hello list,   To clarify, my question (attached below) was prompted by the following from Lexicomp drug interactions:   Contraceptives (Progestins): LamoTRIgine may decrease the serum concentration of Contraceptives (Progestins). ...

[Editorial] The Research Works Act: a damaging threat to science

“Academic publishers have become the enemies of science.” So wrote Dr Mike Taylor, a scientist at the UK's University of Bristol. He, and many scientists like him, are angry that publishers are supporting the Research Works Act (RWA), a controversial Bill before the US Congress.

Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial

Publication year: 2012Source: Schizophrenia Research, Available online 19 January 2012Jens Peter Hansen, Birte Østergaard, Merete Nordentoft, Lise Hounsgaard

Time to act on nonsensical outpatient follow-up ratio targets

A year ago I wrote about imposed targets for outpatient new:follow-up ratios and their impact on chronic disease management,1 receiving many supportive comments in both medical circles and the lay...

Implementation of a clinician administered bowel movement questionnaire for the assessment of clozapine-induced constipation (CIC)

Clozapine, an atypical antipsychotic, is known to cause severe constipation, which can lead to bowel impaction, ischemic bowel, fecal vomitus, and even death. Monitoring suggestions for constipation caused by clozapine are minimal. The intent of this study is to evaluate the possible benefit of implementing a routine monitoring questionnaire to assess for clozapine-induced constipation (CIC).